Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesErectile dysfunction, cardiovascular diseases and depression: interaction of therapy
Expert Opinion in Pharmacotherapy, 07/02/09
El-Sakka AI et al. - The potential effect of medications of each condition on the other conditions had gained a lot of interest. The aim of the current review is to discuss the integrative view of association between cardiovascular diseases, erectile dysfunction and depression, and to address the two direction impact of pharmacotherapy for IHD and depression on erectile function.
Related Articles
Predictors of depression in a multiethnic cohort of patients with rheumatoid arthritis
Arthritis Care and Research, 11/03/09
Relevance Score: 95%
Survival after myocardial infarction worse with first episode major depression than recurrent major depression
Evidence-Based Mental Health, 11/02/09
Relevance Score: 95%
Quality of life and depression among metastatic breast cancer patients
Medical Oncology, 10/05/09
Relevance Score: 95%
Serious diabetes-specific emotional problems in patients with type 2 diabetes who have different levels of comorbid depression: A Polish study from the European Depression in Diabetes (EDID) Research Consortium
European Psychiatry, 11/06/09
Relevance Score: 94%
A systematic review of longitudinal studies on the association between depression and smoking in adolescents
BMC Public Health, 10/01/09
Relevance Score: 94%
Today in Cardiac/Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Polypill: the evidence and the promise
Current Opinion in Lipidology, 12/15/09
Combination therapy of statins and fibrates in the management of cardiovascular risk
Current Opinion in Lipidology, 12/15/09
Personalized antiplatelet therapy for coronary artery disease patients: is this the future?
Expert Review of Cardiovascular Therapy , 12/15/09
Today in Drug Interactions...keeping you current
Receive free subspecialty "5-minute updates" via email
'Party pill' drugs - BZP and TFMPP
New Zealand Medical Journal, 12/14/09
A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism
Alimentary Pharmacology and Therapeutics, 12/10/09
Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD)
Archives of Gerontology and Geriatrics, 12/09/09
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Long-term levetiracetam treatment in patients with epilepsy: 3-year follow up
Acta Neurologica Scandinavica, 12/15/09
Milnacipran: Beyond a Role of Antidepressant
Clinical Neuropharmacology, 12/15/09
Treatment with Olanzapine is Associated with Modulation of the Default Mode Network in Patients with Schizophrenia
Neuropsychopharmacology, 12/15/09
Today in Other Drugs...keeping you current
Receive free subspecialty "5-minute updates" via email
Chitosan-tripolyphosphate nanoparticles as a possible skin drug delivery system for aciclovir with enhanced stability
Journal of Pharmacy and Pharmacology, 12/15/09
Novel TNF antagonists for the treatment of rheumatoid arthritis
Expert Opinion on Investigational Drugs, 12/15/09
Genentech and Biogen Idec Announce Positive Results From First Phase III Trial of Ocrelizumab in Rheumatoid Arthritis
Genentech, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor